Other languages Jubilant Pharmova Limited

Equities

JUBLPHARMA

INE700A01033

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-07-05 am EDT			5-day change	1st Jan Change
750.8 ^INR	+0.26%		+1.59%	+37.56%

Jun. 25	Jubilant Pharmova Arm Completes Prepayment of $75 Million Term Loan	MT
Jun. 18	Jubilant Pharmova Gets 15 Observations from US FDA for Unit's Manufacturing Facility in Canada; Shares Dip 3%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jubilant Pharmova Gets 15 Observations from US FDA for Unit's Manufacturing Facility in Canada; Shares Dip 3%	Jun. 18
Jubilant Pharmova Unit to Prepay $75 Million Term Loan	Jun. 17
Jubilant Pharma Unit to Invest $50 Million for PET Radiopharmacy Network Expansion in US	Jun. 17
Jubilant Pharmova Gets Three US FDA Observations for Unit's Facility in Washington; Shares Drop 3%	Jun. 10
Jubilant Pharmova Narrows Loss in Fiscal Q4	May. 30
India's Jubilant Pharmova reports narrower fourth-quarter loss	May. 29
Jubilant Pharmova Limited Announces Resignation of Jinang Pratap Parekh as Whole-Time Director, Effective May 31, 2024	May. 29
Jubilant Pharmova Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	May. 29
Jubilant Pharmova Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 29
Jubilant Pharmova Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 29
Jubilant Pharmova Appoints CEO for Radiopharma Business	May. 02
Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	Apr. 24
India's Jubilant Pharmova posts quarterly profit	Feb. 02
Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 02
Jubilant Pharmova Limited Announces the Resignation of Kumar Ramamurthi as Director and Whole-Time Director, Effective October 31, 2023	23-10-27
Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-27
Domino's India operator Jubilant beats Q2 profit estimates on cheaper launches	23-10-25
Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2023, Payable on or Before September 29, 2023	23-08-07
Jubilant Pharmova Limited Recommends Dividend for the Financial Year Ended March 31, 2023	23-07-31
Jubilant Pharmova's Consolidated Profit Plunges in Fiscal Q1	23-07-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jubilant Pharmova Limited

Equities

JUBLPHARMA

INE700A01033

Other languages

Filters